A New Diagnosis-Specific Survival Score for Patients to be Irradiated for Brain Metastases from Non-small Cell Lung Cancer
Authors:
- 29 March 2019
- journal article
- research article
- Published by Springer Nature in Lung
- Vol. 197 (3) , 321-326
Abstract
Personalized treatment helps one achieve optimal outcomes in patients with non-small cell lung cancer (NSCLC). Understanding patients’ survival prognoses in a palliative situation like intracerebral metastases is critical. A new survival score, the WBRT-30-NSCLC, was developed for patients with intracerebral metastases from NSCLC.Keywords
This publication has 16 references indexed in Scilit:
- Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trialNeuro-Oncology, 2013
- A new survival score for patients with brain metastases who received whole-brain radiotherapy (WBRT) aloneRadiotherapy and Oncology, 2013
- A new survival score for patients with brain metastases from non-small cell lung cancerStrahlentherapie und Onkologie, 2013
- Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guidelinePractical Radiation Oncology, 2012
- Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain MetastasesJournal of Clinical Oncology, 2012
- Dose‐escalation of whole‐brain radiotherapy for brain metastasis in patients with a favorable survival prognosisCancer, 2011
- Radiation Therapy for Metastatic Disease2011
- Reduction of Overall Treatment Time in Patients Irradiated for More Than Three Brain MetastasesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Radiation‐induced dementia in patients cured of brain metastasesNeurology, 1989
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958